Additionally, vaccinees (n = 20) of 30-day-interval doses showed a significantly higher expression of both CD4+ and CD4+CD45RO+ cells only at D7 and D33 (3 days after the 2nd dose) with AKI-MP stimulation. This evidence concerns the gene CD4 and acute kidney injury.